Related Experiment Video

Updated: Jun 26, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Chlamydia trachomatis genotypes associated with pneumonia in Chilean infants

Maria A Martinez1, Francisca Millan, Cecilia Gonzalez

  • 1Programme of Microbiology, Faculty of Medicine, University of Chile, Santiago de Chile. mamartin@med.uchile.cl

Scandinavian Journal of Infectious Diseases
|January 30, 2009
PubMed

Insights

Chlamydia trachomatis (C. trachomatis) was found in 18.1% of infant pneumonia cases. Serovar E was most common, with genetic variations in the omp1 gene observed.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Molecular Epidemiology

Background:

  • Chlamydia trachomatis (C. trachomatis) is a significant cause of pneumonia in infants.
  • Understanding the genetic diversity of C. trachomatis is crucial for diagnostics and public health.

Purpose of the Study:

  • To determine the serovar distribution of C. trachomatis in infant pneumonia cases.
  • To analyze the genetic variability of the omp1 gene in detected C. trachomatis strains.

Main Methods:

  • Polymerase Chain Reaction (PCR) was used to detect C. trachomatis in nasopharyngeal aspirates.
  • Nucleotide sequencing of the omp1 gene was performed for genetic analysis.

Main Results:

  • C. trachomatis was detected in 18.1% (17/94) of infant pneumonia specimens.
  • Serovar E was the predominant serovar (47.1%), followed by F (17.6%) and Ja (17.6%).
  • Analysis revealed polymorphism within the omp1 gene sequences.

Conclusions:

  • C. trachomatis is a relevant pathogen in infant pneumonia with a notable serovar distribution.
  • Genetic variability in the omp1 gene suggests ongoing evolution and potential implications for diagnostics.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: